Latest News about BMY
Recent news which mentions BMY
Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government
August 25, 2023
From Benzinga
As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list
August 25, 2023
From MarketWatch
From Benzinga
From InvestorPlace
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
From InvestorPlace
Bristol-Myers Squibb Unusual Options Activity For August 21
August 21, 2023
Tickers
BMY
From Benzinga
2 Dividend Stocks to Buy Hand Over Fist
August 16, 2023
From Motley Fool
2 Blue Chip Dividend Stocks That Are Top Buys in August
August 14, 2023
From Motley Fool
UnitedHealth Group, Pioneer Natural Resources And A Credit Card Giant: CNBC's 'Final Trades'
August 14, 2023
From Benzinga
From Benzinga
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
July 31, 2023
From Benzinga
From InvestorPlace
Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations
July 28, 2023
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Friday
July 28, 2023
From Benzinga
From Benzinga
Tickers
BMY
From Motley Fool
Stocks That Hit 52-Week Lows On Thursday
July 27, 2023
From Benzinga
Bristol Myers Squibb's Stocks Falls on Q2 Miss, FY23 Forecast Cut As Two Of Its Top Drugs Face Generic Competition
July 27, 2023
Tickers
BMY
From Benzinga
2 Dirt Cheap Dividend Stocks to Buy Right Now
July 27, 2023
From Motley Fool
US Stocks Buckle Up For Solid Open On Meta's Earnings Boost, Fed Relief — But Analyst Advises Some 'Value-Style' Rebalancing
July 27, 2023
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.